Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001391694 | SCV001593318 | likely benign | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003132494 | SCV003808906 | uncertain significance | not provided | 2020-10-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004545225 | SCV004756846 | likely benign | MPL-related disorder | 2023-05-24 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001836393 | SCV002089518 | likely benign | Congenital amegakaryocytic thrombocytopenia | 2019-10-23 | no assertion criteria provided | clinical testing |